- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.08. | ONS data reveals significant decrease in COVID-19 antibodies | ||
| 12.08. | Roche's Xofluza issued FDA approval to treat influenza in children aged five years and older | ||
| 11.08. | How the Royal Society's EiR programme can help to drive UK innovation | ||
| 11.08. | BMS and 2seventy bio announce positive results for multiple myeloma treatment | ||
| 11.08. | Roche and Cend Therapeutics to evaluate pancreatic cancer combination therapy | ||
| 11.08. | Aqilion initiates phase 1 clinical trial for chronic inflammatory diseases | ||
| 11.08. | JCVI publishes statement on London polio vaccination strategy | ||
| 11.08. | AstraZeneca and Daiichi Sankyo announce results for lung cancer therapy | ||
| 10.08. | My body. My choice. Are we all talking about the same thing? | ||
| 10.08. | BeiGene announces positive phase 3 trial results for liver cancer treatment | ||
| 10.08. | Sanofi halts recruitment for trials assessing MS treatment | ||
| 10.08. | Merck and Cerevance to research novel targets in Alzheimer's disease | ||
| 10.08. | Michael J Fox Foundation awards Koneksa second research grant | ||
| 10.08. | FDA approves Bot Image's AI software for the detection and diagnosis of prostate cancer | ||
| 09.08. | Strategic commitment | ||
| 09.08. | Pfizer set to acquire Global Blood Therapeutics in deal worth $5.4bn | ||
| 09.08. | AstraZeneca and Daiichi Sankyo get FDA approval for breast cancer drug | ||
| 09.08. | NHS England launches hepatitis C screening scheme to reach 2030 elimination goal | ||
| 09.08. | Bayer's Nubeqa receives FDA approval to treat metastatic prostate cancer | ||
| 09.08. | Valneva and Pfizer initiate phase 3 Lyme disease vaccine study | ||
| 08.08. | Born strategic - Why great strategists are both born and made | ||
| 08.08. | AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn | ||
| 08.08. | ONS records a continued fall in UK COVID-19 infections | ||
| 08.08. | ICR research shows how skin cancer cells invade new tissues | ||
| 08.08. | bluebird bio reveals plans to launch two gene therapies |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
